Characterization of follicular T helper cells and donor-specific T helper cells in renal transplant patients with de novo donor-specific HLA-antibodies

Copyright © 2021 Elsevier Inc. All rights reserved.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 226(2021) vom: 07. Mai, Seite 108698
1. Verfasser: Subburayalu, Julien (VerfasserIn)
Weitere Verfasser: Dolff, Sebastian, Xu, Shilei, Sun, Ming, Lindemann, Monika, Heinold, Andreas, Heinemann, Falko M, Tervaert, Jan Willem Cohen, Eisenberger, Ute, Korth, Johannes, Brinkhoff, Alexandra, Kribben, Andreas, Witzke, Oliver, Wilde, Benjamin
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2021
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Research Support, Non-U.S. Gov't Allospecific T cell reactivity Antibody-mediated rejection Solid organ transplantation T follicular helper cell T follicular regulatory cell de novo donor-specific HLA-antibodies Antibodies HLA Antigens mehr... Interleukins Receptors, CXCR5 interleukin-21 MKM3CA6LT1
LEADER 01000naa a22002652 4500
001 NLM321971825
003 DE-627
005 20231225181034.0
007 cr uuu---uuuuu
008 231225s2021 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.clim.2021.108698  |2 doi 
028 5 2 |a pubmed24n1073.xml 
035 |a (DE-627)NLM321971825 
035 |a (NLM)33639275 
035 |a (PII)S1521-6616(21)00035-8 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Subburayalu, Julien  |e verfasserin  |4 aut 
245 1 0 |a Characterization of follicular T helper cells and donor-specific T helper cells in renal transplant patients with de novo donor-specific HLA-antibodies 
264 1 |c 2021 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 24.06.2021 
500 |a Date Revised 24.06.2021 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a Copyright © 2021 Elsevier Inc. All rights reserved. 
520 |a T follicular helper (TFH) cells are a heterogeneous subset of immunocompetent T helper (TH) cells capable of augmenting B cell responses in lymphoid tissues. In transplantation, exposure to allogeneic tissue activates TFH cells increasing the risk of the emergence of de novo donor-specific HLA-antibodies (dnDSA). These can cause antibody-mediated rejection (AMR) and allograft loss. Follicular regulatory T (TFR) cells counteract TFH cell activity. Here, we investigated the implications of TFH and TFR cells on dnDSA formation after renal transplantation (RTX). Considering TFH cells to be CXCR5+ and IL-21+, we found by flow cytometry that patients with dnDSA produced IL-21 more abundantly compared to healthy volunteers. In in vitro alloreactivity assays, patients with dnDSA featured an enhanced alloreactive TH cell pool in response to donor-specific HLA antigens. Besides, longitudinal investigations suggested enhanced alloreactivity shortly after transplantation increasing the risk of dnDSA development. Taken together, in spite of continuous immunosuppression we report a strong IL-21 response in TFH cells and an expanded reservoir of donor-specific memory TH cells in patients with dnDSA. This warrants further investigations if aberrant TFH cell activation may precede the formation of dnDSA promoting AMR 
650 4 |a Journal Article 
650 4 |a Research Support, Non-U.S. Gov't 
650 4 |a Allospecific T cell reactivity 
650 4 |a Antibody-mediated rejection 
650 4 |a Solid organ transplantation 
650 4 |a T follicular helper cell 
650 4 |a T follicular regulatory cell 
650 4 |a de novo donor-specific HLA-antibodies 
650 7 |a Antibodies  |2 NLM 
650 7 |a HLA Antigens  |2 NLM 
650 7 |a Interleukins  |2 NLM 
650 7 |a Receptors, CXCR5  |2 NLM 
650 7 |a interleukin-21  |2 NLM 
650 7 |a MKM3CA6LT1  |2 NLM 
700 1 |a Dolff, Sebastian  |e verfasserin  |4 aut 
700 1 |a Xu, Shilei  |e verfasserin  |4 aut 
700 1 |a Sun, Ming  |e verfasserin  |4 aut 
700 1 |a Lindemann, Monika  |e verfasserin  |4 aut 
700 1 |a Heinold, Andreas  |e verfasserin  |4 aut 
700 1 |a Heinemann, Falko M  |e verfasserin  |4 aut 
700 1 |a Tervaert, Jan Willem Cohen  |e verfasserin  |4 aut 
700 1 |a Eisenberger, Ute  |e verfasserin  |4 aut 
700 1 |a Korth, Johannes  |e verfasserin  |4 aut 
700 1 |a Brinkhoff, Alexandra  |e verfasserin  |4 aut 
700 1 |a Kribben, Andreas  |e verfasserin  |4 aut 
700 1 |a Witzke, Oliver  |e verfasserin  |4 aut 
700 1 |a Wilde, Benjamin  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Clinical immunology (Orlando, Fla.)  |d 1999  |g 226(2021) vom: 07. Mai, Seite 108698  |w (DE-627)NLM098196855  |x 1521-7035  |7 nnns 
773 1 8 |g volume:226  |g year:2021  |g day:07  |g month:05  |g pages:108698 
856 4 0 |u http://dx.doi.org/10.1016/j.clim.2021.108698  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_24 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 226  |j 2021  |b 07  |c 05  |h 108698